DSpace@İnönü

NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic

Basit öğe kaydını göster

dc.contributor.author Berdeli, A
dc.contributor.author Mir, S
dc.contributor.author Yavascan, O
dc.contributor.author Serdaroglu, E
dc.contributor.author Bak, M
dc.contributor.author Aksu, N
dc.contributor.author Oner, A
dc.contributor.author Anarat, A
dc.contributor.author Donmez, O
dc.contributor.author Yildiz, N
dc.contributor.author Sever, L
dc.contributor.author Tabel, Y
dc.contributor.author Dusunsel, R
dc.contributor.author Sonmez, F
dc.contributor.author Cakar, N
dc.date.accessioned 2022-10-19T11:24:49Z
dc.date.available 2022-10-19T11:24:49Z
dc.date.issued 2007
dc.identifier.uri http://hdl.handle.net/11616/83098
dc.description.abstract dThe podocin (NPHS2) gene encodes podocin protein, which has an important role in glomerular ultrafiltration and controlling slit membrane permeability. The detection of an NPHS2 mutation affects the treatment plan for children with nephritic syndrome (NS). The frequency and spectrum of podocin mutations in the Turkish population have remained largely unknown. The aim of this study was to screen for podocin mutations in Turkish patients with steroid-resistant NS (SRNS) and to compare it with other published series. There were 295 children with SRNS, originating from Turkey, included in this study. Forty-one patients (13.8%) had familial NS and 254 patients (86.2%) had sporadic NS. Mutation analysis was performed in all eight exons of the NPHS2 gene with the direct DNA sequencing method. There were 53 different pathogenetic NPHS2 mutations detected, including 37 novel mutations. The mutation detection rate was 24.7% for all patients, 29.2% for familial, and 24% for sporadic SRNS. The most common mutated exon was exon 5 ( 52 allele). The presence of mutations in exon 4 was found to increase the risk of end-stage renal disease ( ESRD). Among patients with mutations, the rates of renal failure and/or ESRD (26%) were significantly higher than in those without mutations (12.6%). The mean time of progression to renal failure and ESRD in patients with mutations (1.8 +/- 2.5 years) was significantly shorter than in patients without mutations (3.7 +/- 4.0 years). Additionally, in patients with heterozygote mutations, fewer cases (13.6%) progressed to renal failure and/ or ESRD than in with patients who had homozygote/ compound heterozygote mutations (31.3%). In conclusion, podocin mutations are responsible for some of both familial and sporadic SRNS cases in Turkey. The mutations in this gene should be searched for in every child after presentation with the first episode of NS.
dc.description.abstract C1 Ege Univ, Fac Med, Dept Mol Genet, Izmir, Turkey.
dc.description.abstract Behcet Uz Childrens Hosp, Izmir, Turkey.
dc.description.abstract Tepecik Teaching & Res Hosp, Izmir, Turkey.
dc.description.abstract Sami Ulus Childrens Hosp, Ankara, Turkey.
dc.description.abstract Cukurova Univ, Fac Med, Adana, Turkey.
dc.description.abstract Uludag Univ, Fac Med, Bursa, Turkey.
dc.description.abstract Goztepe Teaching & Res Hosp, Izmir, Turkey.
dc.description.abstract Istanbul Univ, Cerrahpasa Fac Med, Istanbul, Turkey.
dc.description.abstract Inonu Univ, Fac Med, Malatya, Turkey.
dc.description.abstract Erciyes Univ, Fac Med, Kayseri, Turkey.
dc.description.abstract Adnan Menderes Univ, Fac Med, Aydin, Turkey.
dc.description.abstract Ankara Diskapi Educ & Res Hosp, Ankara, Turkey.
dc.source PEDIATRIC NEPHROLOGY
dc.title NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic
dc.title syndrome


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster